IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 106 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,352,000 | -62.4% | 2,539,154 | -47.6% | 0.00% | -66.7% |
Q1 2018 | $8,921,000 | +9.7% | 4,848,557 | +25.8% | 0.01% | +9.1% |
Q4 2017 | $8,133,000 | +123.3% | 3,854,325 | +135.9% | 0.01% | +83.3% |
Q3 2017 | $3,643,000 | +311.2% | 1,633,651 | +217.1% | 0.01% | +200.0% |
Q2 2017 | $886,000 | -64.3% | 515,186 | -48.7% | 0.00% | -60.0% |
Q1 2017 | $2,480,000 | +256.8% | 1,004,119 | +116.9% | 0.01% | +400.0% |
Q4 2016 | $695,000 | +28.9% | 463,024 | +120.0% | 0.00% | 0.0% |
Q3 2016 | $539,000 | +82.7% | 210,429 | +138.8% | 0.00% | 0.0% |
Q3 2015 | $295,000 | -12.5% | 88,111 | -3.1% | 0.00% | 0.0% |
Q2 2015 | $337,000 | -95.4% | 90,943 | -95.3% | 0.00% | -92.3% |
Q1 2015 | $7,255,000 | -34.6% | 1,955,464 | -22.3% | 0.01% | -45.8% |
Q4 2014 | $11,092,000 | +305.3% | 2,515,159 | +110.5% | 0.02% | +300.0% |
Q3 2014 | $2,737,000 | -27.3% | 1,194,772 | -8.0% | 0.01% | -40.0% |
Q2 2014 | $3,766,000 | -64.9% | 1,298,544 | -50.7% | 0.01% | -67.7% |
Q1 2014 | $10,736,000 | -31.6% | 2,631,353 | -22.3% | 0.03% | -38.0% |
Q4 2013 | $15,688,000 | +2091.1% | 3,388,433 | +723.2% | 0.05% | +2400.0% |
Q3 2013 | $716,000 | – | 411,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |